APO RESEARCH · REPORT
GMP Cytokines
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
Product & engineering
Understand the product.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Selected research
Industry Growth & Trends
Global GMP Cytokines Industry Growth and Trends Forecast to 2032
Market perspective
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Global key players of GMP Cytokines include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva and Lonza, etc. Top three players occupy for a share about 46%. North America is the largest market, with a share about 54%, followed by Europe and Asia-Pacific. In terms of product, Growth Factor is the largest segment, with a share over 55%. In terms of application, Cell/Gene Therapy is the largest market, with a share over 54%.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global GMP Cytokines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The GMP Cytokines market size, estimates, and forecasts are presented in terms of sales volume (mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GMP Cytokines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GMP Cytokines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global GMP Cytokines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
GMP Cytokines Market by Company
Miltenyi Biotec
Bio-Techne
Cytiva
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog
GMP Cytokines Segment by Type
TNF
Interleukin
Growth Factor
Others
GMP Cytokines Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
GMP Cytokines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cytokines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cytokines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cytokines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of GMP Cytokines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- TNF
- Interleukin
- Growth Factor
- Others
Applications
- Cell/Gene Therapy
- Tissue-Engineered Products
- Others
Companies covered
- Miltenyi Biotec
- Bio-Techne
- Cytiva
- Lonza
- CellGenix
- ReproCELL
- PeproTech
- Sino Biological
- Creative Bioarray
- Akron Biotech
- Almog
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global GMP Cytokines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global GMP Cytokines Sales Estimates and Forecasts (2021-2032)
- 1.3 GMP Cytokines Market by Type
- 1.3.1 TNF
- 1.3.2 Interleukin
- 1.3.3 Growth Factor
- 1.3.4 Others
- 1.4 Global GMP Cytokines Market Size by Type
- 1.4.1 Global GMP Cytokines Market Size Overview by Type (2021-2032)
- 1.4.2 Global GMP Cytokines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global GMP Cytokines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America GMP Cytokines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe GMP Cytokines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific GMP Cytokines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America GMP Cytokines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa GMP Cytokines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 GMP Cytokines Industry Trends
- 2.2 GMP Cytokines Industry Drivers
- 2.3 GMP Cytokines Industry Opportunities and Challenges
- 2.4 GMP Cytokines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by GMP Cytokines Revenue (2021-2026)
- 3.2 Global Top Players by GMP Cytokines Sales (2021-2026)
- 3.3 Global Top Players by GMP Cytokines Price (2021-2026)
- 3.4 Global GMP Cytokines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GMP Cytokines Major Company Production Sites & Headquarters
- 3.6 Global GMP Cytokines Company, Product Type & Application
- 3.7 Global GMP Cytokines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global GMP Cytokines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 GMP Cytokines Players Market Share by Revenue in 2025
- 3.8.3 2025 GMP Cytokines Tier 1, Tier 2, and Tier 3
4 GMP Cytokines Regional Status and Outlook
- 4.1 Global GMP Cytokines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global GMP Cytokines Historic Market Size by Region
- 4.2.1 Global GMP Cytokines Sales in Volume by Region (2021-2026)
- 4.2.2 Global GMP Cytokines Sales in Value by Region (2021-2026)
- 4.2.3 Global GMP Cytokines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global GMP Cytokines Forecasted Market Size by Region
- 4.3.1 Global GMP Cytokines Sales in Volume by Region (2027-2032)
- 4.3.2 Global GMP Cytokines Sales in Value by Region (2027-2032)
- 4.3.3 Global GMP Cytokines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GMP Cytokines by Application
- 5.1 GMP Cytokines Market by Application
- 5.1.1 Cell/Gene Therapy
- 5.1.2 Tissue-Engineered Products
- 5.1.3 Others
- 5.2 Global GMP Cytokines Market Size by Application
- 5.2.1 Global GMP Cytokines Market Size Overview by Application (2021-2032)
- 5.2.2 Global GMP Cytokines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global GMP Cytokines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America GMP Cytokines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe GMP Cytokines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific GMP Cytokines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America GMP Cytokines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa GMP Cytokines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Miltenyi Biotec
- 6.1.1 Miltenyi Biotec Company Information
- 6.1.2 Miltenyi Biotec Business Overview
- 6.1.3 Miltenyi Biotec GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Miltenyi Biotec GMP Cytokines Product Portfolio
- 6.1.5 Miltenyi Biotec Recent Developments
- 6.2 Bio-Techne
- 6.2.1 Bio-Techne Company Information
- 6.2.2 Bio-Techne Business Overview
- 6.2.3 Bio-Techne GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bio-Techne GMP Cytokines Product Portfolio
- 6.2.5 Bio-Techne Recent Developments
- 6.3 Cytiva
- 6.3.1 Cytiva Company Information
- 6.3.2 Cytiva Business Overview
- 6.3.3 Cytiva GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cytiva GMP Cytokines Product Portfolio
- 6.3.5 Cytiva Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lonza GMP Cytokines Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 CellGenix
- 6.5.1 CellGenix Company Information
- 6.5.2 CellGenix Business Overview
- 6.5.3 CellGenix GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 CellGenix GMP Cytokines Product Portfolio
- 6.5.5 CellGenix Recent Developments
- 6.6 ReproCELL
- 6.6.1 ReproCELL Company Information
- 6.6.2 ReproCELL Business Overview
- 6.6.3 ReproCELL GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 ReproCELL GMP Cytokines Product Portfolio
- 6.6.5 ReproCELL Recent Developments
- 6.7 PeproTech
- 6.7.1 PeproTech Company Information
- 6.7.2 PeproTech Business Overview
- 6.7.3 PeproTech GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 PeproTech GMP Cytokines Product Portfolio
- 6.7.5 PeproTech Recent Developments
- 6.8 Sino Biological
- 6.8.1 Sino Biological Company Information
- 6.8.2 Sino Biological Business Overview
- 6.8.3 Sino Biological GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sino Biological GMP Cytokines Product Portfolio
- 6.8.5 Sino Biological Recent Developments
- 6.9 Creative Bioarray
- 6.9.1 Creative Bioarray Company Information
- 6.9.2 Creative Bioarray Business Overview
- 6.9.3 Creative Bioarray GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Creative Bioarray GMP Cytokines Product Portfolio
- 6.9.5 Creative Bioarray Recent Developments
- 6.10 Akron Biotech
- 6.10.1 Akron Biotech Company Information
- 6.10.2 Akron Biotech Business Overview
- 6.10.3 Akron Biotech GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Akron Biotech GMP Cytokines Product Portfolio
- 6.10.5 Akron Biotech Recent Developments
- 6.11 Almog
- 6.11.1 Almog Company Information
- 6.11.2 Almog Business Overview
- 6.11.3 Almog GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Almog GMP Cytokines Product Portfolio
- 6.11.5 Almog Recent Developments
7 North America by Country
- 7.1 North America GMP Cytokines Sales by Country
- 7.1.1 North America GMP Cytokines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America GMP Cytokines Sales by Country (2021-2026)
- 7.1.3 North America GMP Cytokines Sales Forecast by Country (2027-2032)
- 7.2 North America GMP Cytokines Market Size by Country
- 7.2.1 North America GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America GMP Cytokines Market Size by Country (2021-2026)
- 7.2.3 North America GMP Cytokines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe GMP Cytokines Sales by Country
- 8.1.1 Europe GMP Cytokines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe GMP Cytokines Sales by Country (2021-2026)
- 8.1.3 Europe GMP Cytokines Sales Forecast by Country (2027-2032)
- 8.2 Europe GMP Cytokines Market Size by Country
- 8.2.1 Europe GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe GMP Cytokines Market Size by Country (2021-2026)
- 8.2.3 Europe GMP Cytokines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific GMP Cytokines Sales by Country
- 9.1.1 Asia-Pacific GMP Cytokines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific GMP Cytokines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific GMP Cytokines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific GMP Cytokines Market Size by Country
- 9.2.1 Asia-Pacific GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific GMP Cytokines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific GMP Cytokines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America GMP Cytokines Sales by Country
- 10.1.1 South America GMP Cytokines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America GMP Cytokines Sales by Country (2021-2026)
- 10.1.3 South America GMP Cytokines Sales Forecast by Country (2027-2032)
- 10.2 South America GMP Cytokines Market Size by Country
- 10.2.1 South America GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America GMP Cytokines Market Size by Country (2021-2026)
- 10.2.3 South America GMP Cytokines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa GMP Cytokines Sales by Country
- 11.1.1 Middle East and Africa GMP Cytokines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa GMP Cytokines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa GMP Cytokines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa GMP Cytokines Market Size by Country
- 11.2.1 Middle East and Africa GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa GMP Cytokines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa GMP Cytokines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 GMP Cytokines Value Chain Analysis
- 12.1.1 GMP Cytokines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 GMP Cytokines Production Mode & Process
- 12.2 GMP Cytokines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 GMP Cytokines Distributors
- 12.2.3 GMP Cytokines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst